- Home
- BWA vs CRL Comparison
BWA vs CRL Comparison
Compare BWA & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWA
- CRL
- Stock Information
- Founded
- BWA 1987
- CRL 1947
- Country
- BWA United States
- CRL United States
- Employees
- BWA N/A
- CRL N/A
- Industry
- BWA Auto Parts:O.E.M.
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BWA Consumer Discretionary
- CRL Health Care
- Exchange
- BWA Nasdaq
- CRL Nasdaq
- Market Cap
- BWA 6.3B
- CRL 7.3B
- IPO Year
- BWA 1993
- CRL 2000
- Fundamental
- Price
- BWA $44.33
- CRL $156.97
- Analyst Decision
- BWA Buy
- CRL Buy
- Analyst Count
- BWA 14
- CRL 15
- Target Price
- BWA $42.14
- CRL $186.64
- AVG Volume (30 Days)
- BWA 2.2M
- CRL 755.3K
- Earning Date
- BWA 10-30-2025
- CRL 11-05-2025
- Dividend Yield
- BWA 1.56%
- CRL N/A
- EPS Growth
- BWA N/A
- CRL N/A
- EPS
- BWA 0.95
- CRL N/A
- Revenue
- BWA $14,041,000,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- BWA $2.03
- CRL N/A
- Revenue Next Year
- BWA $2.69
- CRL $2.16
- P/E Ratio
- BWA $43.66
- CRL N/A
- Revenue Growth
- BWA N/A
- CRL N/A
- 52 Week Low
- BWA $24.40
- CRL $91.86
- 52 Week High
- BWA $44.65
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- BWA 65.66
- CRL 48.18
- Support Level
- BWA $43.26
- CRL $149.90
- Resistance Level
- BWA $44.70
- CRL $159.78
- Average True Range (ATR)
- BWA 0.77
- CRL 6.03
- MACD
- BWA -0.19
- CRL -0.77
- Stochastic Oscillator
- BWA 89.02
- CRL 41.31
About BWA BorgWarner Inc.
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.